Literature DB >> 26733722

Mechanism of vascular dysfunction due to circulating factors in women with pre-eclampsia.

Cindy K Kao1, Jude S Morton1, Anita L Quon1, Laura M Reyes2, Patricio Lopez-Jaramillo3, Sandra T Davidge4.   

Abstract

Circulating factors have been proposed to play a major role in the pathophysiology of endothelial dysfunction in pre-eclampsia (PE), which is defined as new-onset hypertension with proteinuria after 20 weeks of gestation. However, the mechanisms leading to altered vascular reactivity remain unclear. We hypothesized that circulating factors lead to endothelial dysfunction by increasing oxidative stress and reducing nitric oxide (NO) and prostaglandin (PG) bioavailability. Pregnant rat uterine and mesenteric arteries were incubated overnight with 3% normotensive (NP) or PE plasma collected from women upon admission to hospital. Responses to methacholine (MCh) were obtained using wire myography to assess endothelial function pathways. Vascular superoxide level was measured via dihydroethidium staining and nitric oxide synthase (NOS) expression via Western blots. PE plasma significantly increased superoxide levels and impaired endothelial dysfunction in uterine arteries (Emax 79.9±5.6% compared with 44.9±6.3%, P=0.0004), which was restored in the presence of oxidant scavengers or PG synthesis inhibition. Uterine artery vasodilation was abolished in the presence of pan-NOS inhibitor (P<0.0001) in both NP- and PE-treated vessels, but inducible nitric oxide synthase (iNOS)-dependent vasodilation was present only in NP-treated arteries. Uterine arteries exposed to PE plasma exhibit an increased endothelial NOS expression and a decreased iNOS expression. PE plasma did not alter endothelial function in mesenteric arteries, suggesting that the effect of circulating factors was vascular-bed-specific. We have shown that circulating factors lead to endothelial dysfunction via altered oxidative stress and vasodilator pathways. The present study contributes to our understanding of the pathophysiology and finding a potential target for intervention in PE.
© 2016 Authors; published by Portland Press Limited.

Entities:  

Keywords:  circulating factors; endothelium; nitric oxide; pre-eclamptic plasma; prostaglandin; uterine artery

Mesh:

Substances:

Year:  2016        PMID: 26733722     DOI: 10.1042/CS20150678

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

1.  Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction.

Authors:  Bhavisha A Bakrania; Frank T Spradley; Heather A Drummond; Babbette LaMarca; Michael J Ryan; Joey P Granger
Journal:  Compr Physiol       Date:  2020-12-09       Impact factor: 9.090

Review 2.  Uteroplacental Circulation in Normal Pregnancy and Preeclampsia: Functional Adaptation and Maladaptation.

Authors:  Xiangqun Hu; Lubo Zhang
Journal:  Int J Mol Sci       Date:  2021-08-11       Impact factor: 5.923

3.  Cerebrovascular Reactivity and Vascular Activation in Postmenopausal Women With Histories of Preeclampsia.

Authors:  Jill N Barnes; Ronée E Harvey; Kathleen B Miller; Muthuvel Jayachandran; Katherine R Malterer; Brian D Lahr; Kent R Bailey; Michael J Joyner; Virginia M Miller
Journal:  Hypertension       Date:  2017-11-20       Impact factor: 10.190

4.  NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia.

Authors:  Daniela A Pereira; Valeria C Sandrim; Ana C Palei; Lorena M Amaral; Vanessa A Belo; Riccardo Lacchini; Ricardo C Cavalli; Jose E Tanus-Santos; Marcelo R Luizon
Journal:  Pharmacogenomics       Date:  2021-05-04       Impact factor: 2.638

5.  Placental Vesicles Carry Active Endothelial Nitric Oxide Synthase and Their Activity is Reduced in Preeclampsia.

Authors:  Carolina Motta-Mejia; Neva Kandzija; Wei Zhang; Vuyane Mhlomi; Ana Sofia Cerdeira; Alexandra Burdujan; Dionne Tannetta; Rebecca Dragovic; Ian L Sargent; Christopher W Redman; Uday Kishore; Manu Vatish
Journal:  Hypertension       Date:  2017-06-12       Impact factor: 10.190

6.  Mechanisms of vascular dysfunction in the interleukin-10-deficient murine model of preeclampsia indicate nitric oxide dysregulation.

Authors:  Hajrunisa Cubro; Karl A Nath; Sonja Suvakov; Oscar Garcia-Valencia; Santosh Parashuram; Wendy M White; Tracey L Weissgerber; Meryl C Nath; Natasa M Milic; Fernando Sontag; Livius V d'Uscio; Yi Zhu; James L Kirkland; Tamar Tchkonia; Mariam P Alexander; Reade A Quinton; Zvonimir S Katusic; Joseph P Grande; Vesna D Garovic
Journal:  Kidney Int       Date:  2020-11-02       Impact factor: 10.612

7.  Kolaviron attenuated arsenic acid induced-cardiorenal dysfunction via regulation of ROS, C-reactive proteins (CRP), cardiac troponin I (CTnI) and BCL2.

Authors:  Ademola Adetokunbo Oyagbemi; Temidayo Olutayo Omobowale; Ebunoluwa Racheal Asenuga; John Olusoji Abiola; Adeolu Alex Adedapo; Momoh Audu Yakubu
Journal:  J Tradit Complement Med       Date:  2017-12-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.